Alteron Therapeutics is a biotech startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death. By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.
Founded date: 2017
Investors 1
Date | Name | Website |
30.10.2020 | Lair East ... | laireastla... |